• Profile
Close

Performance of two-stage cervical cancer screening with primary high-risk human papillomavirus testing in women living with human immunodeficiency virus

Obstetrics and Gynecology Oct 04, 2019

Luckett R, Mogowa N, Li HJ, et al. - The performance of cervical cancer screening algorithms using primary high-risk human papillomavirus (HPV) testing followed by cytology, visual inspection with acetic acid, or colposcopy, for women living with HIV was evaluated. Researchers performed a prospective cohort study of 300 women living with HIV in Botswana. Among these, a positive high-risk HPV test result was reported in 88 (29%); 29/88 (35%) women had CIN 2 or higher on histopathology. In a high-risk population with HIV, the highest sensitivity and PPV in detecting high-grade cervical dysplasia were evident with high-risk HPV testing followed by colposcopy. They suggest a higher efficacy of allocating resources to colposcopy in resource-limited settings than other screening strategies. High-risk HPV followed by colposcopy showed a sensitivity of 83%, a specificity of 49%, PPV of 47%, likelihood ratios (LR)+ of +1.6, and LR− of −0.4.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay